Cargando…
Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease
INTRODUCTION: There is a need for a reliable, noninvasive biomarker for Alzheimer's disease (AD). We assessed whether short-latency afferent inhibition (SAI), a transcranial magnetic stimulation paradigm that assesses cholinergic circuits of the brain, could become such a biomarker. METHODS: Ni...
Autores principales: | Hwang, Yun Tae, Rocchi, Lorenzo, Hammond, Paul, Hardy, Chris JD., Warren, Jason D., Ridha, Basil H., Rothwell, John, Rossor, Martin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857494/ https://www.ncbi.nlm.nih.gov/pubmed/29560413 http://dx.doi.org/10.1016/j.trci.2018.02.001 |
Ejemplares similares
-
Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Hardy, Chris J. D., et al.
Publicado: (2017) -
A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study
por: Ridha, Basil H., et al.
Publicado: (2018) -
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
por: Pachón-Angona, Irene, et al.
Publicado: (2019) -
Donepezil improves vascular function in a mouse model of Alzheimer’s disease
por: Pellegrini, Carolina, et al.
Publicado: (2021) -
Effect of Transcranial Direct Current Stimulation Combined with Donepezil on stroke patients with memory impairment
por: Hu, Wenqing, et al.
Publicado: (2023)